144 related articles for article (PubMed ID: 33989408)
1. Evolution of the Neurosurgeon's Role in Clinical Trials for Glioblastoma: A Systematic Overview of the Clinicaltrials.Gov Database.
Mansouri A; Beyn ME; Pancholi A; Chow CT; Wang R; Boutet A; Elias GJB; Germann J; Loh A; Voisin MR; Lozano AM; Chiocca EA; Vogelbaum MA; Zadeh G
Neurosurgery; 2021 Jul; 89(2):196-203. PubMed ID: 33989408
[TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
3. The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?
Vanderbeek AM; Rahman R; Fell G; Ventz S; Chen T; Redd R; Parmigiani G; Cloughesy TF; Wen PY; Trippa L; Alexander BM
Neuro Oncol; 2018 Jul; 20(8):1034-1043. PubMed ID: 29518210
[TBL] [Abstract][Full Text] [Related]
4. Clinical trials using oncolytic viral therapy to treat adult glioblastoma: a progress report.
Lu VM; Shah AH; Vallejo FA; Eichberg DG; Luther EM; Shah SS; Komotar RJ; Ivan ME
Neurosurg Focus; 2021 Feb; 50(2):E3. PubMed ID: 33524946
[TBL] [Abstract][Full Text] [Related]
5. Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.gov.
Cihoric N; Tsikkinis A; Minniti G; Lagerwaard FJ; Herrlinger U; Mathier E; Soldatovic I; Jeremic B; Ghadjar P; Elicin O; Lössl K; Aebersold DM; Belka C; Herrmann E; Niyazi M
Radiat Oncol; 2017 Jan; 12(1):1. PubMed ID: 28049492
[TBL] [Abstract][Full Text] [Related]
6. The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I-III Studies.
Cho NS; Wong WK; Nghiemphu PL; Cloughesy TF; Ellingson BM
Curr Oncol Rep; 2023 Sep; 25(9):1047-1055. PubMed ID: 37402043
[TBL] [Abstract][Full Text] [Related]
7. Comparison of reporting phase I trial results in ClinicalTrials.gov and matched publications.
Shepshelovich D; Goldvaser H; Wang L; Abdul Razak AR; Bedard PL
Invest New Drugs; 2017 Dec; 35(6):827-833. PubMed ID: 28905282
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
9. Analysis of factors leading to early termination in glioblastoma-related clinical trials.
Shah HA; Mishra A; Gouzoulis MJ; Ben-Shalom N; D'Amico RS
J Neurooncol; 2022 Jul; 158(3):489-495. PubMed ID: 35648307
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A
JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198
[TBL] [Abstract][Full Text] [Related]
11. Combination immunotherapy strategies for glioblastoma.
Chan HY; Choi J; Jackson C; Lim M
J Neurooncol; 2021 Feb; 151(3):375-391. PubMed ID: 33611705
[TBL] [Abstract][Full Text] [Related]
12. Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications.
Hartung DM; Zarin DA; Guise JM; McDonagh M; Paynter R; Helfand M
Ann Intern Med; 2014 Apr; 160(7):477-83. PubMed ID: 24687070
[TBL] [Abstract][Full Text] [Related]
13. Current landscape of type 1 diabetes mellitus-related interventional clinical trials registered on ClinicalTrials.gov: a cross-sectional study.
Liang R; Long J; Zheng Q; Yuan G; Chen X; Xin Z; Lai F; Liu Y
Acta Diabetol; 2021 Jun; 58(6):723-733. PubMed ID: 33543370
[TBL] [Abstract][Full Text] [Related]
14. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).
Oehlke O; Mix M; Graf E; Schimek-Jasch T; Nestle U; Götz I; Schneider-Fuchs S; Weyerbrock A; Mader I; Baumert BG; Short SC; Meyer PT; Weber WA; Grosu AL
BMC Cancer; 2016 Oct; 16(1):769. PubMed ID: 27716184
[TBL] [Abstract][Full Text] [Related]
15. Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives.
Zhu P; Zhu JJ
Chin Clin Oncol; 2017 Aug; 6(4):41. PubMed ID: 28841803
[TBL] [Abstract][Full Text] [Related]
16. Trends in Immunotherapy Clinical Trials to Treat Glioblastoma: A Look at Progress and Challenges.
Price G; Rossitto CP; Price H; Hadjipanayis C; Martini M
World Neurosurg; 2023 Oct; 178():e819-e827. PubMed ID: 37574192
[TBL] [Abstract][Full Text] [Related]
17. Systematic review of interventional sickle cell trials registered in ClinicalTrials.gov.
Lebensburger JD; Hilliard LM; Pair LE; Oster R; Howard TH; Cutter GR
Clin Trials; 2015 Dec; 12(6):575-83. PubMed ID: 26085544
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Oncology Trial Results Reporting Over a 10-Year Period.
Liu X; Zhang Y; Li WF; Vokes E; Sun Y; Le QT; Ma J
JAMA Netw Open; 2021 May; 4(5):e2110438. PubMed ID: 34028549
[TBL] [Abstract][Full Text] [Related]
19. Clinical research in surgical oncology: an analysis of ClinicalTrials.gov.
Menezes AS; Barnes A; Scheer AS; Martel G; Moloo H; Boushey RP; Sabri E; Auer RC
Ann Surg Oncol; 2013 Nov; 20(12):3725-31. PubMed ID: 23800894
[TBL] [Abstract][Full Text] [Related]
20. Recurrent glioblastoma: a fresh look at current therapies and emerging novel approaches.
Gilbert MR
Semin Oncol; 2011 Dec; 38 Suppl 4():S21-33. PubMed ID: 22078645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
